Key moments in Genzyme's history

1991 - Key drug approved by the FDA Ceredase, a treatment for Gaucher's disease, gains FDA approval after seven years of work on the drug by Genzyme. First patients pay over $300,000 for the first year of treatment, making it one of the most expensive medications in the world. Pictured: A photo showing a reunion of nine of the original 12 participants in the Ceredase clinical trial hangs in Termeer's office.
Reuters Photo

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Compiled by Jesse Nunes, Boston.com Staff

1991 - Key drug approved by the FDA

Ceredase, a treatment for Gaucher's disease, gains FDA approval after seven years of work on the drug by Genzyme. First patients pay over $300,000 for the first year of treatment, making it one of the most expensive medications in the world.

Pictured: A photo showing a reunion of nine of the original 12 participants in the Ceredase clinical trial hangs in Termeer's office.